$MYL Sets Up as Prime Coronavirus Therapy Play

MYL is going to be very interesting in the weeks ahead as the "chloroquine theory" gets more testing as a COVID-19 frontline therapeutic. The stock has a Green Light from the Ichimoku Cloud and a breakout set up at $17.50/share.